Results 191 to 200 of about 17,593 (256)

Androgen metabolism in prostate cancer: recent advances.

Endocrinology
Sharifi N.
europepmc   +1 more source

What is the need for adrenalectomy in patients with congenital adrenal hyperplasia in the era of CRF1/ACTH inhibitors? [PDF]

Front Endocrinol (Lausanne)
Fedorova O, Falhammar H.
europepmc   +1 more source

Effects of GLP‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review

International Journal of Dermatology, EarlyView.
Miranda K. Branyiczky, Megan S. Lowe, Eric McMullen, Jeffrey Donovan, Touraj Khosravi‐Hafshejani   +4 more
wiley   +1 more source

Effect of live‐high, train‐low strategy induced by chronic low‐dose carbon monoxide exposure on haematological parameters and performance in trained individuals

Experimental Physiology, EarlyView.
Abstract Altitude training enhances haematological adaptations and endurance at sea level, typically requiring exposure to ∼2500 m altitude for 3–4 weeks. Emerging evidence suggests that low‐dose carbon monoxide (CO) inhalation might mimic hypoxia and might be used by elite athletes.
Simone Villanova, Simone Porcelli, Lena Ekström, Daniele A. Cardinale   +3 more
wiley   +1 more source

Comment on Reiss et al. The Effect of Androgen Deprivation Therapy on the Cardiovascular System in Advanced Prostate Cancer. <i>Medicina</i> 2024, <i>60</i>, 1727. [PDF]

Medicina (Kaunas)
Ufer M, Rakov VG.
europepmc   +1 more source

Comparative analysis of OECD guideline data and Tox21 assays to improve reproductive and developmental toxicity prediction. [PDF]

Sci Rep
Kwon HJ, Lee H, Lee S, Ko W, Yun SJ, Uesawa Y, Jung J.   +6 more
europepmc   +1 more source

Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer. [PDF]

Proc Natl Acad Sci U S A
Traphagen NA, Wheeler E, Li R, Akhshi T, Ravindranathan R, Alfieri C, Lu F, Ahmed B, Tewari AK, Balk SP, Nelson PS, Corey E, Long H, D'Andrea AD, Qiu X, Brown M.   +15 more
europepmc   +1 more source

Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer. [PDF]

Oncogene
Brooke GN, Leach DA, Culley RL, Azadova A, Latonen L, Rees E, Alkheilewi MA, Pine AC, Fioretti FM, Reader CS, Powell SM, Reebye V, Waxman J, Visakorpi T, Bevan CL.   +14 more
europepmc   +1 more source

Emerging Medical Therapies for Primary Aldosteronism. [PDF]

Hypertension
Vibhatavata P, Turcu AF.
europepmc   +1 more source